Skip to main content

Elisenda Anglada Clofent

-

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Neuropsychologist
Multiple Sclerosis Centre of Catalonia
Elisenda Anglada Clofent

Elisenda Anglada Clofent

Elisenda Anglada Clofent

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Neuropsychologist
Multiple Sclerosis Centre of Catalonia

-

-

Projects

SGR-Cat 2021: Neuroimmunologia Clínica

IP: SGR-Cat 2021: Neuroimmunologia Clínica
Collaborators: Carlos Nos Llopis, SGR-Cat 2021: Neuroimmunologia Clínica, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Andrea Serrano Mascarós, Margarida Capell Maymo, Samuel Sánchez Pous, Elisenda Anglada Clofent, Montserrat Aroca Alsina, Sergio Cabello, Carmen Tur Gomez, Gabriel Ig Camiña Rodríguez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Edwin Roger Meza Murillo, Augusto Cesar Sao Aviles, Miguel Angel Robles Sanchez, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Gaizka Loyola Sanmillan, Mireia Resina Salles, Angela Vidal Jordana, Lucía Gutiérrez Ruiz, Ana Zabalza de Torres, Sergio Vergara Ruiz, Rafael Garcia Merida, Luciana Midaglia Fernandez, Alvaro Cobo Calvo, Neus Mongay Ochoa, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Andres Miguez Gonzalez, Mireia Castillo Juarez, Rucsanda Pinteac, Nicolás Miguel Fissolo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00782
Duration: 01/01/2022 - 30/06/2025

Incorporación de la caracterización estructuro-funcional medular por resonancia magnética. Aplicación en la esclerosis múltiple.

IP: Deborah Pareto Onghena
Collaborators: Jordi Rio Izquierdo, Elisenda Anglada Clofent, Elena Huerga Núñez
Funding agency: Instituto de Salud Carlos III
Funding: 37510
Reference: PI18/00823
Duration: 01/01/2019 - 30/06/2023

Related news

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Lourdes Zamorano Moreno

Lourdes Zamorano Moreno

Gestió i Administració
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Daniel Eiroa Gutierrez

Daniel Eiroa Gutierrez

Research technician
Molecular Imaging and Therapy
Read more
Cándido Muñoz Muñoz

Cándido Muñoz Muñoz

Predoctoral researcher
Systemic Diseases
Read more
Josep Paunellas Albert

Josep Paunellas Albert

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.